• 1
    Vail DM and Young KM. Canine lymphoma and lymphoid leukemia. In: Withrow and MacEwen's Small Animal Clinical Oncology, 4th edn., SJ Withrow and DM Vail, eds., St. Louis, WB Saunders Co, 2007: 699712.
  • 2
    Vail DM, Michels GM, Khanna C, Selting KA, London CA and the Veterinary Cooperative Oncology Group. Response evaluation criteria for peripheral nodal lymphoma in dogs (v1.0)—a Veterinary Cooperative Oncology Group (VCOG) consensus document. Veterinary and Comparative Oncology 2010; 8: 2837.
  • 3
    Flory AB, Rassnick KM, Stokol T, Scrivani PV and Erb HN. Stage migration in dogs with lymphoma. Journal of Veterinary Internal Medicine 2007; 21: 10411047.
  • 4
    Marconato L, Stefanello D, Valenti P, Bonfanti U, Comazzi S, Roccabianca P, Caniatti M, Romanelli G, Massari F and Zini E. Predictors of long-term survival in dogs with high-grade multicentric lymphoma. Journal of the American Veterinary Medical Association 2011; 238: 480485.
  • 5
    Marconato L, Bonfanti U, Stefanello D, Lorenzo MR, Romanelli G, Comazzi S and Zini E. Cytosine arabinoside in addition to VCAA-based protocols for the treatment of canine lymphoma with bone marrow involvement: does it make the difference? Veterinary and Comparative Oncology 2008; 6: 8089.
  • 6
    Williams MJ, Avery AC, Lana SE, Hillers KR, Bachand AM and Avery PR. Canine lymphoproliferative disease characterized by lymphocytosis: immunophenotypic markers of prognosis. Journal of Veterinary Internal Medicine 2008; 22: 596601.
  • 7
    Rao S, Lana S, Eickhoff J, Marcus E, Avery PR, Morley PS and Avery AC. Class II major histocompatibility complex expression and cell size independently predict survival in canine B-cell lymphoma. Journal of Veterinary Internal Medicine 2011; 25: 10971105.
  • 8
    Gelain ME, Mazzilli M, Riondato F, Marconato L and Comazzi S. Aberrant phenotypes and quantitative antigen expression in different subtypes of canine lymphoma by flow cytometry. Veterinary Immunology and Immunopathology 2008; 121(3–4): 179188.
  • 9
    Dobson AJ and Barnett A. An Introduction to Generalized Linear Models. 3rd edn., Boca Raton, Chapman and Hall/CRC Press, 2008.
  • 10
    Zelenetz AD, Abramson JS, Advani RH, Andreadis CB, Bartlett N, Bellam N, Byrd JC, Czuczman MS, Fayad LE, Glenn MJ, Gockerman JP, Gordon LI, Harris NL, Hoppe RT, Horwitz SM, Kelsey CR, Kim YH, LaCasce AS, Nademanee A, Porcu P, Press O, Pro B, Reddy N, Sokol L, Swinnen LJ, Tsien C, Vose JM, Wierda WG, Yahalom J and Zafar N. Non-Hodgkin's lymphomas. Journal of the National Comprehensive Cancer Network 2011; 9: 484560.
  • 11
    Hanson CA, Kurtin PJ, Katzmann JA, Hover JD, Li CY, Hodnefield JM, Meyers CH, Habermann TM and Witzig TE. Immunophenotypic analysis of peripheral blood and bone marrow in the staging of B-cell malignant lymphoma. Blood 1999; 94: 38893896.
  • 12
    Talaulikar D, Shadbolt B, Dahlstrom JE and McDonald A. Routine use of ancillary investigations in staging diffuse large B-cell lymphoma improves the International Prognostic Index (IPI). Journal of Hematology & Oncology 2009; 2: 49.
  • 13
    Graff E, Spangler E, Smith A, Brauss M and Denhre M. Hematologic abnormalities associated with the presence of lymphoma in the bone marrow of dogs [abstract 12]. Veterinary Clinical Pathology 2011; 40: 603.
  • 14
    Comazzi S and Gelain ME. Use of flow cytometric immunophenotyping to refine the cytological diagnosis of canine lymphoma. The Veterinary Journal 2011; 188: 149155.
  • 15
    Kiupiel M, Teske E and Bostock D. Prognostic factors for treated canine malignant lymphoma. Veterinary Pathology 1999; 36: 292300.
  • 16
    Ponce F, Magnol JP, Ledieu D, Marchal T, Turinelli V, Chalvet-Monfray K and Fournel-Fleury C. Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy. The Veterinary Journal 2004; 167: 158166.
  • 17
    Grindem CB, Page RL, Ammerman BE and Breitschwerdt EB. Immunophenotypic comparison of blood and lymph node from dogs with lymphoma. Veterinary Clinical Pathology 1998; 27: 1620.
  • 18
    Joetze AE, Eberle N, Nolte I, Mischke R and Simon D. Flow cytometric evaluation of peripheral blood and bone marrow and fine-needle aspirate samples from multiple sites in dogs with multicentric lymphoma. American Journal of Veterinary Research 2012; 73: 884893.
  • 19
    Faldyna M, Sinkora J, Knotigova P, Rehakova Z, Moravkova A and Toman M. Flow cytometric analysis of bone marrow leukocytes in neonatal dogs. Veterinary Immunology and Immunopathology 2003; 95: 165176.
  • 20
    Chen LP, Lin SJ and Yu MS. Prognostic value of platelet count in diffuse large B-cell lymphoma. Clinical Lymphoma, Myeloma & Leukemia 2012; 12: 3237.
  • 21
    Abbo AH and Lucroy MD. Assessment of anemia as an independent predictor of response to chemotherapy and survival in dogs with lymphoma: 96 cases (1993–2006). Journal of the American Veterinary Medical Association 2007; 231: 18361842.
  • 22
    Miller AG, Morkley PS, Rao S, Avery AC, Lana SE and Olver CS. Anemia is associated with decreased survival time in dogs with lymphoma. Journal of Veterinary Internal Medicine 2009; 23: 116122.